What’s going on over at Rothschild RX?

Based on the most helpful WSO content, Rothschild's RX team has been highlighted as a strong franchise with great exit opportunities and a solid reputation in the restructuring space. However, there are some notable dynamics to consider:

1. Team Changes: It appears that Rothschild has experienced some turnover in its RX team, including the departure of Lazard MDs who were brought on a few years ago. While the reasons for these departures aren't explicitly detailed, such changes can sometimes reflect shifts in strategy, market conditions, or internal restructuring.

2. US Practice Impact: Despite these changes, Rothschild's US practice overall is described as rapidly expanding, with a strong culture of retaining talent across levels. The firm is known for its focus on deal volume rather than size, and its RX team continues to be recognized for providing strong exit opportunities.

3. Comparison to Other EBs: The RX space has seen increased competition from newer boutiques like PJT and Ducera, which have been gaining market share. This competitive environment might contribute to talent movement across firms. Additionally, other EBs like Greenhill and Centerview have their own unique RX dynamics, such as flexible mandates or generalist programs.

While team turnover can raise questions, Rothschild's RX group remains a respected player in the market, and the broader US practice seems to be on solid footing.

Sources: Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups, Rothschild NYC Groups, Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups, RX Rankings 2022 - Can we please get restructuring rankings for the benefit of students and incoming interns looking to lateral, Rothschild (NYC) Groups 2022